N

Neurology Associates of Ormond Beach | Ormond Beach, FL

Research site
(Unclaimed)
Location
8 Mirror Lake Drive, Suite C, Ormond Beach, Florida, United States of America

Site insights

Top conditions

Top treatments

Atogepant
Eslicarbazepine Acetate
Levodopa
Orelabrutinib
Ozanimod
Ofatumumab
Teriflunomide
GV-971
IMU-838
Erenumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 30 total trials

A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis

This is a randomized, double-Blind, placebo-controlled Phase 2 Study of Orelabrutinib in Patients with Relapsing-Remitting Multiple Sclerosis.

Active, not recruiting
Relapsing Remitting Multiple Sclerosis
Other: placebo
Drug: orelabrutinib

A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis who are tra...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Ofatumumab

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

This study is designed to evaluate the safety and efficacy of dipraglurant in PD patients with dyskinesia (randomized 1:1 to receive active or placeb...

Enrolling
Parkinson Disease
Dyskinesia, Drug-Induced
Drug: Dipraglurant
Drug: Placebo

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Enrolling
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have particip...

Enrolling
Relapsing Multiple Sclerosis
Biological: 13-valent pneumococcal conjugate vaccine (13-PCV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Re...

Enrolling
Multiple Sclerosis
Drug: IMU-838 tablets
Drug: Placebo matching IMU-838 tablets

A Randomized, Double-blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients with Early Alzheimer's Di...

Active, not recruiting
Alzheimer's Disease
Drug: Placebo
Drug: BPN14770

Trial sponsors

Novartis logo
Sumitomo Pharma logo
Allergan logo
Eisai logo
Acadia Pharmaceuticals logo
Actelion Pharmaceuticals logo
A
Amgen logo
Avanir Pharmaceuticals logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems